Page 41 - Read Online

Page 12 of 13 Piñeiro et al. J Cancer Metastasis Treat 2021;7:10 I http://dx.doi.org/10.20517/2394-4722.2020.115

34. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin 2016;66:115-32.
35. Chamilos G, Lionakis MS, Kontoyiannis DP. Are all patients with cancer at heightened risk for severe Coronavirus Disease 2019
(COVID-19)? Clin Infect Dis 2020;ciaa1079.
36. Zhang L, Zhu F, Xie L, et al. Clinical characteristics of COVID19-infected cancer patients: A retrospective case study in three hospitals
within Wuhan, China. Ann Oncol 2020;31:894-901.
37. Kuderer NM, Choueiri TK, Shah DP, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): A cohort study. Lancet
2020;395:1907-18.
38. Lee LY, Cazier JB, Angelis V, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a
prospective cohort study. Lancet 2020;395:1919-26.
39. ASCO special report: a guide to cancer care delivery during the COVID-19 pandemic. Available from: https://www.asco.org/sites/new-
www.asco.org/files/content-files/2020-ASCO-Guide-Cancer-COVID19.pdf. [Last accesses on 2 Feb 2021]
40. Posicionamiento-recomendaciones SEOM sobre el cribado serológico previo al inicio de una quimioterapia inmunosupresora
durante la pandemia COVID-19. Paciente asintomático sin infección COVID-19 conocida. Available from: https://seom.org/images/
Posicionamiento_TESTS_COVID_QUIMIO.pdf. [Last accesses on 2 Feb 2021]
41. Di Giacomo AM, Gambale E, Monterisi S, Valente M, Maio M. SARS-COV-2 infection in patients with cancer undergoing checkpoint
blockade: Clinical course and outcome. Eur J Cancer 2020;133:1-3.
42. COVID-19 Provider and Practice information. Available from: https://www.asco.org/asco-coronavirus-information/provider-practice-
preparedness-covid-19. [Last accesses on 2 Feb 2021]
43. Coccia M. Path-breaking target therapies for lung cancer and a far-sighted health policy to support clinical and cost effectiveness. Health
Policy Technol 2014;3:74-82.
44. Zhang H, Xie C, Huang Y. Treatment and outcome of a patient with lung cancer Infected with severe acute respiratory syndrome
Coronavirus-2. J Thorac Oncol 2020;15:e63-4.
45. COVID-19 rapid guideline: Delivery of radiotherapy. Available from: https://www.nice.org.uk/guidance/ng162/chapter/4-Patients-with-
symptoms-of-COVID-19-at-presentation. [Last accesses on 2 Feb 2021]
46. Purandare NC, Rangarajan V. Imaging of lung cancer: implications on staging and management. Indian J Radiol Imaging 2015;25:109-
20.
47. Xu B, Xing Y, Peng J, et al. Chest CT for detecting COVID-19: a systematic review and meta-analysis of diagnostic accuracy. Eur Radiol
2020;30:5720-7.
48. Ai T, Yang Z, Hou H, et al. Correlation of chest CT and RT-PCR testing for Coronavirus Disease 2019 (COVID-19) in China: a report of
1014 cases. Radiology 2020;296:E32-E40.
49. Xu B, Xing Y, Peng J, et al. (2020) Chest CT for detecting COVID-19: a systematic review and meta-analysis of diagnostic accuracy. Eur
Radiol 2020;30:5720-7.
50. Liu M, Zeng W, Wen Y, Zheng Y, Lv F, Xiao K. COVID-19 pneumonia: CT findings of 122 patients and differentiation from influenza
pneumonia. Eur Radiol 2020;30:5463-9.
51. Shaverdian N, Shepherd AF, Rimner A, et al. Need for caution in the diagnosis of radiation pneumonitis during the COVID-19 pandemic.
Adv Radiat Oncol 2020;5:617-20.
52. Nishino M, Ramaiya NH, Awad MM, et al. PD-1 inhibitor-related pneumonitis in advanced cancer patients: Radiographic patterns and
clinical course. Clin Cancer Res 2016;22:6051-60.
53. Wang Y, Dong C, Hu Y, et al. Temporal changes of CT findings in 90 patients with COVID-19 pneumonia: a longitudinal study.
Radiology 2020;296:E55-E64.
54. Coccia M. Deep learning technology for improving cancer care in society: new directions in cancer imaging driven by artificial
intelligence. Technology in Society 2020;60:101198.
55. Patt D, Gordan L, Diaz M, et al. Impact of COVID-19 on cancer care: how the pandemic is delaying cancer diagnosis and treatment for
American seniors. JCO Clin Cancer Inform 2020;4:1059-71.
56. Singh AP, Berman AT, Marmarelis ME, et al. Management of lung cancer during the COVID-19 pandemic. JCO Oncol Pract
2020;16:579-86.
57. Indini A, Aschele C, Cavanna L, et al. Reorganisation of medical oncology departments during the novel coronavirus disease-19
pandemic: a nationwide Italian survey. Eur J Cancer 2020;132:17-23.
58. Wang XS, Zeng M. Challenges for a cancer center in the Novel Coronavirus Pneumonia epidemic. Technol Cancer Res Treat
2020;19:1533033820945774.
59. Mazzone PJ, Gould MK, Arenberg DA, et al. Management of lung nodules and lung cancer screening during the COVID-19 pandemic:
CHEST expert panel report. Chest 2020;158:406-15.
60. Lonergan PE, Washington Iii SL, Branagan L, et al. Rapid utilization of telehealth in a comprehensive cancer center as a response to
COVID-19: cross-sectional analysis. J Med Internet Res 2020;22:e19322.
61. Oropallo A. Coronavirus disease 2019 (COVID-19): Issues related to wound care a telehealth managemen. UptoDate. [Last Accessed on
2 Feb 2021]
62. Dinesen B, Nonnecke B, Lindeman D, et al. Personalized telehealth in the future: a global research agenda. J Med Internet Res
2016;18:e53.
63. Higgison IJ, Sen-Gupta GJ. Place of care in advanced cancer: a qualitative systematic literature review of patient preferences. J Palliat
Med 2000;3:287-300.